CVE-2026-19008: A vulnerability was identified in mf-yang openclaw-cn up to 0.2.1
CVE-2026-19008 is a medium-severity flaw (CVSS 6.3) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability was identified in mf-yang openclaw-cn up to 0.2.1. This issue affects the function assertNoSymlinkEscape of the file src/agents/sandbox-paths.ts of the component apply_patch Tool. Such manipulation leads to link following. It is possible to launch the attack remotely. The exploit is publicly available and might be used. The project was informed of the problem early through an issue report but has not responded yet.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.3 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.4% (top 63%) |
| CISA exploited list | No |
| Weakness | CWE-59 |
| Published | 2026-08-06 |
| Last modified | 2026-10-23 |
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-19008?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-19008 being exploited?
CVE-2026-19008 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-19008 affect?
CVE-2026-19008 affects affected software. Severity is medium (CVSS 6.3). A vulnerability was identified in mf-yang openclaw-cn up to 0.2.1. This issue affects the function assertNoSymlinkEscape of the file src/agents/sandbox-paths.ts of the component apply_patch Tool. Such manipulation leads to link following. I
How urgent is CVE-2026-19008?
Priority 31/100. No elevated risk signals yet.